Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Endocrinology|May 10, 2019
Genes Involved in Oxidative Stress Pathways Are Differentially Expressed in Circulating Mononuclear Cells Derived From Obese Insulin-Resistant and Lean Insulin-Sensitive Individuals Following a Single Mixed-Meal ChallengeSonia Baig, Ehsan Parvaresh Rizi, Chelsea Chia, et al.American Heart Journal|August 30, 2023
Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarctionStefan James, David Erlinge, Robert F Storey, et al.Lancet (London, England)|June 8, 2026
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trialMelanie J Davies, Vanita R Aroda, Julio Rosenstock, et al.Nutrition Journal|December 2, 2016
Meal rich in carbohydrate, but not protein or fat, reveals adverse immunometabolic responses associated with obesityEhsan Parvaresh Rizi, Sonia Baig, Muhammad Shabeer, et al.BMJ Open Diabetes Research & Care|February 13, 2020
Heredity of type 2 diabetes confers increased susceptibility to oxidative stress and inflammationSonia Baig, Muhammad Shabeer, Ehsan Parvaresh Rizi, et al.Journal of the American Heart Association|July 29, 2025
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI TrialRobert F Storey, John Deanfield, Stefan James, et al.The Journal of Clinical Endocrinology and Metabolism|August 27, 2015
Ethnic Differences in the Role of Adipocytokines Linking Abdominal Adiposity and Insulin Sensitivity Among AsiansEhsan Parvaresh Rizi, Yvonne Teo, Melvin Khee-Shing Leow, et al.ESC Heart Failure|September 17, 2025
Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MIDavid Erlinge, Stefan James, John Deanfield, et al.NEJM Evidence|February 6, 2024
Dapagliflozin in Myocardial Infarction without Diabetes or Heart FailureStefan James, David Erlinge, Robert F Storey, et al.Pageof 2